These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17653121

  • 1. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial.
    Schrier RW, Estacio RO, Mehler PS, Hiatt WR.
    Nat Clin Pract Nephrol; 2007 Aug; 3(8):428-38. PubMed ID: 17653121
    [Abstract] [Full Text] [Related]

  • 2. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO, Jeffers BW, Gifford N, Schrier RW.
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [Abstract] [Full Text] [Related]

  • 3. The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes.
    Savage S, Johnson Nagel N, Estacio RO, Feig PU, MacCarthy EP, Lukken NJ, Ziegler R, Schrier RW.
    Online J Curr Clin Trials; 1993 Nov 24; Doc No 104():[6250 words; 128 paragraphs]. PubMed ID: 8305994
    [Abstract] [Full Text] [Related]

  • 4. Improving the prognosis of diabetic patients: evaluating the role of intensive versus moderate blood pressure control with selective angiotensin II receptor blocker (ARB) therapy.
    Bedigian MP.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun 24; 1(2 Suppl):S25-8. PubMed ID: 17199216
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
    Havranek EP, Esler A, Estacio RO, Mehler PS, Schrier RW, Appropriate Blood Pressure Control in Diabetes Trial.
    Am Heart J; 2003 Jun 24; 145(6):993-8. PubMed ID: 12796754
    [Abstract] [Full Text] [Related]

  • 6. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO, Coll JR, Tran ZV, Schrier RW.
    Am J Hypertens; 2006 Dec 24; 19(12):1241-8. PubMed ID: 17161769
    [Abstract] [Full Text] [Related]

  • 7. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A, Bashir K, Anwar E.
    Nepal Med Coll J; 2007 Jun 24; 9(2):79-83. PubMed ID: 17899953
    [Abstract] [Full Text] [Related]

  • 8. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, Crepaldi G.
    Diabetes Nutr Metab; 2004 Oct 24; 17(5):259-66. PubMed ID: 16295047
    [Abstract] [Full Text] [Related]

  • 9. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G, BENEDICT Study Group.
    J Am Soc Nephrol; 2006 Dec 24; 17(12):3472-81. PubMed ID: 17082240
    [Abstract] [Full Text] [Related]

  • 10. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM.
    Am J Kidney Dis; 2006 Jan 24; 47(1):78-87. PubMed ID: 16377388
    [Abstract] [Full Text] [Related]

  • 11. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group.
    BMJ; 1998 Sep 12; 317(7160):703-13. PubMed ID: 9732337
    [Abstract] [Full Text] [Related]

  • 12. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb 12; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 13. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
    Schrier RW, Estacio RO, Esler A, Mehler P.
    Kidney Int; 2002 Mar 12; 61(3):1086-97. PubMed ID: 11849464
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up after tight control of blood pressure in type 2 diabetes.
    Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR.
    N Engl J Med; 2008 Oct 09; 359(15):1565-76. PubMed ID: 18784091
    [Abstract] [Full Text] [Related]

  • 15. Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990-1994/1995). Results of the JEVIN trial.
    Schiel R, Müller UA, Beltschikow W, Stein G.
    J Diabetes Complications; 2006 Oct 09; 20(5):273-9. PubMed ID: 16949513
    [Abstract] [Full Text] [Related]

  • 16. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
    Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH.
    J Hypertens; 2007 Dec 09; 25(12):2479-85. PubMed ID: 17984670
    [Abstract] [Full Text] [Related]

  • 17. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A, Amer W, Anwar E, Bashir K.
    Saudi J Kidney Dis Transpl; 2009 May 09; 20(3):429-35. PubMed ID: 19414946
    [Abstract] [Full Text] [Related]

  • 18. The role of antihypertensive therapy in reducing vascular complications of type 2 diabetes. Findings from the DIabetic REtinopathy Candesartan Trials-Protect 2 study.
    Tillin T, Orchard T, Malm A, Fuller J, Chaturvedi N.
    J Hypertens; 2011 Jul 09; 29(7):1457-62. PubMed ID: 21602709
    [Abstract] [Full Text] [Related]

  • 19. Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. A 14-year follow-up report on 195 patients.
    Ravid M, Savin H, Lang R, Jutrin I, Shoshana L, Lishner M.
    Arch Intern Med; 1992 Jun 09; 152(6):1225-9. PubMed ID: 1599351
    [Abstract] [Full Text] [Related]

  • 20. Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1.
    Tanaka Y, Daida H, Imai Y, Miyauchi K, Sato Y, Hiwatari M, Kitagawa A, Kishimoto J, Yamazaki T, Kawamori R.
    Hypertens Res; 2009 Sep 09; 32(9):770-4. PubMed ID: 19557003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.